Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
Young adults with acute lymphoblastic leukemia have an excellent outcome with chemotherapy alone and benefit from intensive postinduction treatment: a report from the childrens oncology group
Journal of Clinical Oncology, 10/12/09
Nachman JB et al. – Young adult patients with ALL showing a rapid response to induction chemotherapy benefit from early intensive postinduction therapy but do not benefit from a second interim maintenance and delayed intensification phase. Given the excellent outcome with this chemotherapy, there seems to be no role for the routine use of allogeneic stem-cell transplantation in first remission for young adults with ALL.
Methods- CCG 1961 entered patients with ALL 1 to 21 years of age with initial WBC count ≥ 50,000/?L and/or age ≥ 10 years.
- Randomly assigned therapies evaluated impact of postinduction treatment intensification on outcome
- 5-year event-free and overall survival rates for young adult patients are 71.5% and 77.5%
- Rapid responder patients randomly assigned to augmented therapy had 5-year event-free survival of 81.8% as compared with 66.8% for patients receiving standard therapy
- 1 versus 2 interim maintenance and delayed intensification courses had no significant impact on event-free survival
- WBC count more than 50,000/?L was adverse prognostic factor
Today in Leukemia/Lymphoma...keeping you current
Receive free subspecialty "5-minute updates" via email
Peripheral T-cell lymphoma gene expression profiling and potential therapeutic exploitations
British Journal of Haematology, 11/20/09
Selective depletion of a minor subpopulation of B-chronic lymphocytic leukemia cells is followed by a delayed but progressive loss of bulk tumor cells and disease regression
Molecular Cancer, 11/20/09
Camptothecin and khat (Catha edulis Forsk.) induced distinct cell death phenotypes involving modulation of c-FLIPL, Mcl-1, procaspase-8 and mitochondrial function in acute myeloid leukemia cell lines
Molecular Cancer, 11/20/09
Today in Pediatric Heme/Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Randomized Trial and Pharmacokinetic Study of Pegfilgrastim versus Filgrastim after Dose-Intensive Chemotherapy in Young Adults and Children with Sarcomas
Clinical Cancer Research, 11/20/09
Development and preliminary testing of a Paediatric Version of the Haemophilia Activities List (pedhal)
Haemophilia, 11/18/09
Iron deficiency anemia in infancy and reach and grasp development
Infant Behavior and Development, 11/18/09
Today in Pharmacology/Therapy...keeping you current
Receive free subspecialty "5-minute updates" via email
Toxicity of Bisphosphonates
Journal of Palliative Medicine, 11/20/09
Serum estradiol should be monitored not only during the peri-menopausal period but also the post-menopausal period at the time of aromatase inhibitor administration
World Journal of Surgical Oncology, 11/20/09
Lenalidomide, Melphalan, and Prednisone Association Is an Effective Salvage Therapy in Relapsed Plasma Cell Leukaemia
Journal of Oncology, 11/20/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


